MedTrace Logo

Efficacy and Safety Study of Dietary Supplements in Chronic Smokers Having Mild to Moderate Hyperlipidemia

NCT02100202 · Status: UNKNOWN · Phase: NA · Type: INTERVENTIONAL · Enrollment: 60

Last updated 2014-03-31

No results posted yet for this study

Summary

The purpose of this study is to investigate the efficacy and safety of dietary supplements (BioTurmin, BioTurmin-WD and MaQxan) on cotinine level and oxidative stress marker in chronic smokers having mild to moderate hyperlipidemia after 30 days of intervention.

Conditions

Interventions

OTHER

Placebo

DIETARY_SUPPLEMENT

BioTurmin (Curcuma longa rhizomes extract)

DIETARY_SUPPLEMENT

BioTurmin-WD (Water dispersible curcuminoids)

DIETARY_SUPPLEMENT

MaQxan (Tagetes erecta flower extract)

Sponsors & Collaborators

  • Olive Lifesciences Pvt Ltd

    lead INDUSTRY

Principal Investigators

  • Venkateshwarlu K, MD (Ayur) · Sreenivasa Clinic Diabetic Research Center

Study Design

Allocation
RANDOMIZED
Purpose
PREVENTION
Masking
DOUBLE
Model
PARALLEL

Eligibility

Min Age
20 Years
Max Age
65 Years
Sex
MALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2014-04-30
Primary Completion
2014-07-31
Completion
2014-07-31

Countries

  • India

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02100202 on ClinicalTrials.gov